Ophthalmologists should encourage smoking cessation

Article

There is a need to introduce smoking cessation support into routine ophthalmic practice, according to a report published in the February issue of Eye.

There is a need to introduce smoking cessation support into routine ophthalmic practice, according to a report published in the February issue of Eye.

Simon Kelly and colleagues from the Royal Bolton Hospital, the University of Manchester, Bury Primary Care Trust, UK and the University of Otago, New Zealand conducted a cross-sectional survey using a postal questionnaire of all UK NHS hospital-based consultant ophthalmologists. The questionnaire looked at whether ophthalmologists identify the smoking status of their patients, advise about the increased risk of eye disease amongst smokers and whether they deliver smoking cessation advice. The availability of departmental smoking cessation resources was also ascertained.

Of the 886 ophthalmologists contacted, 485 responded (55%) and of the respondents, 79% were male. Only 35% of respondents asked about smoking status every time or most times for new patients and 5% for follow-up patients. Around 40% claimed to always or usually advise patients to give up smoking and 61% claimed to always or usually mention eye disease as a reason to quit. Just 14% assessed motivation to give up and 22% provide advice and assistance. Female ophthalmologists were more likely to undertake most aspects of smoking assessment and intervention. Only 18% of respondents stated that their department provides information about smoking for patients and 6% said that support is available for patients wanting to give up.

The results of this questionnaire indicate that smoking cessation support is not encouraged enough and should be routine in hospital-based ophthalmic departments.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.